Revision LITT for Epilepsy: How likely are patients to get a second treatment if the first fails?

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY
Nolan Winslow, Alexander Himstead, Sumeet Vadera
{"title":"Revision LITT for Epilepsy: How likely are patients to get a second treatment if the first fails?","authors":"Nolan Winslow,&nbsp;Alexander Himstead,&nbsp;Sumeet Vadera","doi":"10.1016/j.jocn.2025.111235","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Medically-refractory epilepsy is a serious neurological problem. Surgical resection may offer the greatest chance of seizure freedom, but is underutilized. Laser interstitial thermal therapy (LITT) has minimal incision size and variable efficacy by pathology. LITT can be repeated to provide seizure freedom, however, the number of patients who receive subsequent LITT treatments after a failed first attempt is unknown. We aimed to review the literature on this potential patient population who might benefit most from multiple surgical treatments.</div></div><div><h3>Methods</h3><div>We performed a record review of multiple medical databases for studies treating 5 or more epilepsy patients with LITT utilizing the PRISMA guidelines. From the search, we reviewed 55 articles with a total of 1734 patients with at least six months of follow up. We recorded clinical variables, rates of seizure control after LITT, and details of follow up treatments.</div></div><div><h3>Results</h3><div>Of 1734 total epilepsy patients treated with LITT, 46.4 % were listed as seizure free at last follow up. Out of 850 patients with data on additional procedural treatment, 40.5 % were seizure free and 59.5 % had persistent seizures. Of these, 29.1 % received subsequent intervention for continued seizures. These included additional LITT (55.4 %), surgical resections (41.9 %), and neurostimulator placement (2.0 %). Seizure freedom was achieved in 51.20 % of patients undergoing additional LITT, 62.9 % of patients undergoing subsequent surgical resection, and no patient undergoing neurostimulation. Lesions more likely to achieve seizure freedom with LITT were cavernous malformations (66.7 %) and hypothalamic hamartoma (66.4 %). Lesions less likely to achieve seizure freedom with LITT were temporal lobe epilepsy (43.6 %), focal cortical dysplasia (45.5 %), and periventricular nodular heterotopia (35 %).</div></div><div><h3>Conclusion</h3><div>Though LITT has respectable efficacy in epilepsy, not all patients may be participating in subsequent procedures after a failed first treatment. Patients should be advised that repeat LITT or subsequent surgical resection may be necessary for best chance of seizure freedom.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"136 ","pages":"Article 111235"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586825002073","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Medically-refractory epilepsy is a serious neurological problem. Surgical resection may offer the greatest chance of seizure freedom, but is underutilized. Laser interstitial thermal therapy (LITT) has minimal incision size and variable efficacy by pathology. LITT can be repeated to provide seizure freedom, however, the number of patients who receive subsequent LITT treatments after a failed first attempt is unknown. We aimed to review the literature on this potential patient population who might benefit most from multiple surgical treatments.

Methods

We performed a record review of multiple medical databases for studies treating 5 or more epilepsy patients with LITT utilizing the PRISMA guidelines. From the search, we reviewed 55 articles with a total of 1734 patients with at least six months of follow up. We recorded clinical variables, rates of seizure control after LITT, and details of follow up treatments.

Results

Of 1734 total epilepsy patients treated with LITT, 46.4 % were listed as seizure free at last follow up. Out of 850 patients with data on additional procedural treatment, 40.5 % were seizure free and 59.5 % had persistent seizures. Of these, 29.1 % received subsequent intervention for continued seizures. These included additional LITT (55.4 %), surgical resections (41.9 %), and neurostimulator placement (2.0 %). Seizure freedom was achieved in 51.20 % of patients undergoing additional LITT, 62.9 % of patients undergoing subsequent surgical resection, and no patient undergoing neurostimulation. Lesions more likely to achieve seizure freedom with LITT were cavernous malformations (66.7 %) and hypothalamic hamartoma (66.4 %). Lesions less likely to achieve seizure freedom with LITT were temporal lobe epilepsy (43.6 %), focal cortical dysplasia (45.5 %), and periventricular nodular heterotopia (35 %).

Conclusion

Though LITT has respectable efficacy in epilepsy, not all patients may be participating in subsequent procedures after a failed first treatment. Patients should be advised that repeat LITT or subsequent surgical resection may be necessary for best chance of seizure freedom.
癫痫的 LITT 治疗翻版:如果第一次治疗失败,患者接受第二次治疗的可能性有多大?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Neuroscience
Journal of Clinical Neuroscience 医学-临床神经学
CiteScore
4.50
自引率
0.00%
发文量
402
审稿时长
40 days
期刊介绍: This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology. The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信